Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jing-Shing Chen"'
IntroductionAdvanced stage non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations may have benefit from tyrosine kinase inhibitors (TKI). However, the role of multidisciplinary management including neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab5d2a4d7624e3b9b9ec84171e349a00
https://doi.org/10.21203/rs.3.rs-578508/v1
https://doi.org/10.21203/rs.3.rs-578508/v1
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. (5):1182-1184